Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Extracorporeal Membrane Oxygenation Machine Market Analysis

ID: MRFR/HC/6647-HCR
95 Pages
Nidhi Mandole
March 2026

Extracorporeal Membrane Oxygenation Machine (ECMO) Market Research Report: Size, Share, Trend Analysis By Applications (Cardiac Support, Respiratory Support, Cardiopulmonary Bypass), By End Users (Hospitals, Ambulatory Surgical Centers, Home Care Settings), By Product Type (Venoarterial ECMO, Venovenous ECMO, Arteriovenous ECMO), By Component (Membrane Oxygenator, Blood Pumps, Heat Exchangers) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Extracorporeal Membrane Oxygenation Machine Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Methodology Download PDF

Market Analysis

In-depth Analysis of Extracorporeal Membrane Oxygenation Machine Market Industry Landscape

ECMOs provide temporary circulatory and respiratory support to patients with significant heart or lung failure, driving the market. The increased prevalence of ARDS, cardiovascular disease, and other dangerous respiratory or cardiac disorders is a major factor. As ECMO's viability in treating patients with reduced heart and lung function grows, so does demand for cutting-edge and effective ECMOs.

Administrative considerations greatly impact ECMO market aspects. ECMO machines are safe and effective due to strict rules for approving, building, and using clinical devices. Compliance with administrative criteria guides the sale of these life-support devices, boosting medical professionals' and patients' trust. These concepts shape the ECMO industry and improve patient safety.

The affordability and availability of ECMO devices are affected by global economic factors. Financial growth may increase medical care spending and interest in cutting-edge therapeutic advances. However, financial issues may alter medical services expenditure plans, emphasizing smart but effective ECMO setups and shifting market patterns. Research coordination and clinical trials are essential for ECMO developments and clinical needs. Logical investigation helps understand ECMO's role in clinical circumstances, patient outcomes, and predicted entanglements. Continuous research advances ECMO machines, ensuring them meet the latest medical and logical data.

Growing telemedicine and remote medical services affect the ECMO industry. Compact and remotely monitored ECMO options become increasingly relevant as medical care systems explore methods to expand basic care services outside clinic settings. These creative changes align market trends with telehealth and long-term monitoring goals.

Public awareness and training on ECMO in fundamental consideration scenarios boost market growth. Teaching medical professionals, on-call staff, and the public about ECMO equipment shapes market patterns by encouraging proactive medical services commitment and educated crisis decision-making.

Increasing need for integrated and comprehensive basic care affects ECMO market factors. As ECMO moves beyond life-support, coordinated frameworks that seamlessly interface with different monitoring and treatment methods are emerging. This holistic approach to basic care boosts market preferences for comprehensive patient care.

Author
Author Profile
Nidhi Mandole
Senior Research Analyst

She is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Nidhi is comfortably versed in data centric research backed by healthcare educational background. She leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. Her key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, she showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

Get In Touch

Leave a Comment

FAQs

What is the projected market valuation for the Extracorporeal Membrane Oxygenation Machine Market by 2035?

<p>The projected market valuation for the Extracorporeal Membrane Oxygenation Machine Market is expected to reach 3497.62 USD Million by 2035.</p>

Which companies are considered key players in the Extracorporeal Membrane Oxygenation Machine Market?

<p>Key players in the market include Medtronic, Getinge, LivaNova, Fresenius SE, Terumo Corporation, Maquet, Nipro Corporation, and Cleveland Medical Devices.</p>

What was the overall market valuation for the Extracorporeal Membrane Oxygenation Machine Market in 2024?

<p>The overall market valuation for the Extracorporeal Membrane Oxygenation Machine Market was 1863.66 USD Million in 2024.</p>

What is the expected CAGR for the Extracorporeal Membrane Oxygenation Machine Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Extracorporeal Membrane Oxygenation Machine Market during the forecast period 2025 - 2035 is 5.89%.</p>

How does the market segment for Cardiac Support perform in terms of valuation?

<p>The market segment for Cardiac Support is valued between 500.0 and 950.0 USD Million.</p>

What are the projected valuations for Veno-Venous Extracorporeal Membrane Oxygenation by 2035?

<p>The projected valuation for Veno-Venous Extracorporeal Membrane Oxygenation is expected to range from 800.0 to 1300.0 USD Million.</p>

Which end-use segment is expected to have the highest valuation in the Extracorporeal Membrane Oxygenation Machine Market?

<p>The Hospitals segment is expected to have the highest valuation, projected between 800.0 and 1500.0 USD Million.</p>

What is the valuation range for the Oxygenator component in the market?

<p>The valuation range for the Oxygenator component is between 500.0 and 950.0 USD Million.</p>

How does the market for Membrane Technology compare to other technologies in terms of valuation?

<p>The market for Membrane Technology is valued between 763.66 and 1497.62 USD Million, indicating a strong position compared to other technologies.</p>

What is the expected performance of the Extracorporeal Membrane Oxygenation Machine Market by 2035?

<p>The Extracorporeal Membrane Oxygenation Machine Market is expected to demonstrate robust growth, reaching a valuation of 3497.62 USD Million by 2035.</p>

Market Summary

As per MRFR analysis, the Extracorporeal Membrane Oxygenation Machine Market Size was estimated at 1863.66 USD Million in 2024. The Extracorporeal Membrane Oxygenation Machine industry is projected to grow from 1973.43 USD Million in 2025 to 3497.62 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 5.89% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Extracorporeal Membrane Oxygenation Machine Market is experiencing robust growth driven by technological advancements and increasing healthcare demands.

  • Technological advancements in ECMO machines are enhancing performance and patient outcomes.
  • North America remains the largest market, while Asia-Pacific is emerging as the fastest-growing region.
  • The critical care segment is witnessing significant adoption, alongside a growing interest in portable ECMO systems.
  • Rising incidence of respiratory and cardiac diseases, coupled with increased funding for healthcare infrastructure, are key drivers of market growth.

Market Size & Forecast

2024 Market Size 1863.66 (USD Million)
2035 Market Size 3497.62 (USD Million)
CAGR (2025 - 2035) 5.89%
Largest Regional Market Share in 2024 North America

Major Players

<p>Medtronic (US), Getinge (SE), LivaNova (GB), Fresenius SE (DE), Terumo Corporation (JP), Maquet (DE), Nipro Corporation (JP), Cleveland Medical Devices (US)</p>

Market Trends

The Extracorporeal Membrane Oxygenation Machine Market is currently experiencing notable developments driven by advancements in technology and increasing demand for critical care solutions. The integration of innovative features, such as enhanced monitoring systems and improved biocompatibility, appears to be reshaping the landscape of this market. Healthcare providers are increasingly recognizing the potential benefits of these machines in managing severe respiratory and cardiac conditions, which may lead to a broader adoption across various healthcare settings. Furthermore, the growing emphasis on patient-centered care suggests that the market could witness a shift towards more user-friendly designs, facilitating better outcomes for patients and healthcare professionals alike. In addition, the Extracorporeal Membrane Oxygenation Machine Market seems to be influenced by ongoing research and development efforts aimed at optimizing machine performance and safety. Collaborations between manufacturers and healthcare institutions may foster innovation, potentially resulting in more efficient and reliable devices. As the global healthcare landscape evolves, the demand for advanced extracorporeal membrane oxygenation solutions is likely to expand, reflecting a commitment to improving patient care and addressing the complexities of critical illnesses.

Technological Advancements

The Extracorporeal Membrane Oxygenation Machine Market is witnessing rapid technological advancements that enhance machine efficiency and safety. Innovations in materials and design are likely to improve biocompatibility and reduce complications, making these machines more effective in critical care settings.

Increased Adoption in Emerging Markets

There appears to be a growing trend of increased adoption of extracorporeal membrane oxygenation machines in emerging markets. As healthcare infrastructure improves and access to advanced medical technologies expands, these regions may experience a rise in demand for such life-saving equipment.

Focus on Patient-Centric Solutions

The market is shifting towards patient-centric solutions, emphasizing user-friendly designs and improved monitoring capabilities. This trend suggests that manufacturers are prioritizing the needs of both patients and healthcare providers, potentially leading to better clinical outcomes.

Extracorporeal Membrane Oxygenation Machine Market Market Drivers

Growing Awareness and Training Programs

The rise in awareness regarding the benefits of ECMO therapy is significantly impacting the Extracorporeal Membrane Oxygenation Machine Market. Healthcare professionals are increasingly recognizing the importance of ECMO in managing critically ill patients. Consequently, numerous training programs and workshops are being organized to educate medical staff on the effective use of ECMO machines. This heightened awareness is likely to lead to more frequent utilization of ECMO technology in hospitals, thereby driving market growth. Additionally, as more healthcare providers become proficient in ECMO procedures, the demand for these machines is expected to increase, further solidifying their role in critical care.

Technological Advancements in ECMO Machines

The Extracorporeal Membrane Oxygenation Machine Market is experiencing a surge in technological advancements that enhance the efficiency and effectiveness of ECMO machines. Innovations such as miniaturization, improved biocompatible materials, and advanced monitoring systems are being integrated into these devices. For instance, the introduction of portable ECMO systems allows for greater mobility and flexibility in patient care. Furthermore, the incorporation of artificial intelligence and machine learning algorithms into ECMO machines is likely to improve patient outcomes by enabling real-time data analysis and decision-making. As a result, the market is projected to grow at a compound annual growth rate of approximately 8% over the next five years, driven by these technological enhancements.

Emerging Markets and Healthcare Accessibility

The expansion of healthcare access in emerging markets is a pivotal driver for the Extracorporeal Membrane Oxygenation Machine Market. As economies develop, there is a growing emphasis on improving healthcare services, including critical care capabilities. Countries in Asia and Latin America are witnessing an increase in the availability of ECMO machines, driven by both government initiatives and private investments. This trend is likely to enhance the overall healthcare infrastructure, allowing for better management of severe medical conditions. As a result, the demand for ECMO technology is expected to rise, reflecting the increasing focus on advanced medical solutions in these regions.

Increased Funding for Healthcare Infrastructure

Investment in healthcare infrastructure is a crucial factor influencing the Extracorporeal Membrane Oxygenation Machine Market. Governments and private entities are allocating substantial funds to enhance healthcare facilities, particularly in critical care units. This funding is often directed towards acquiring advanced medical equipment, including ECMO machines, to improve patient outcomes. For instance, recent initiatives in various regions have led to the establishment of specialized ECMO centers, which are equipped with state-of-the-art technology. Such developments not only enhance the capacity of healthcare systems but also stimulate demand for ECMO machines, contributing to market expansion.

Rising Incidence of Respiratory and Cardiac Diseases

The increasing prevalence of respiratory and cardiac diseases is a significant driver for the Extracorporeal Membrane Oxygenation Machine Market. Conditions such as acute respiratory distress syndrome (ARDS) and severe cardiac failure necessitate advanced life support systems, including ECMO machines. According to recent health statistics, the incidence of ARDS has been rising, leading to a higher demand for ECMO services in critical care settings. This trend is further exacerbated by an aging population, which is more susceptible to these health issues. Consequently, healthcare facilities are investing in ECMO technology to provide better patient care, thereby propelling market growth.

Market Segment Insights

By Application: Cardiac Support (Largest) vs. Respiratory Support (Fastest-Growing)

<p>In the Extracorporeal Membrane Oxygenation (ECMO) Machine Market, the distribution of application segments showcases distinct preferences among healthcare providers. Cardiac Support remains the leading application, holding the largest share thanks to its critical role in managing acute heart failure and similar conditions. Concurrently, Respiratory Support has emerged as a significant area of growth, driven by increasing respiratory illnesses and a heightened emphasis on advanced life support systems during critical care procedures. The growth trajectory for these segments is underpinned by several factors. For Cardiac Support, a rising patient population with cardiac issues, coupled with the technological advancements in ECMO devices, fosters its dominance. In contrast, Respiratory Support benefits from emerging trends in medical technology and the urgent need for innovative solutions in managing respiratory distress, positioning it as the fastest-growing segment within the ECMO market.</p>

<p>Cardiac Support (Dominant) vs. Extracorporeal Carbon Dioxide Removal (Emerging)</p>

<p>Cardiac Support is recognized as the dominant application within the Extracorporeal Membrane Oxygenation Machine Market, reflecting its widespread use in critical care settings to support patients with severe cardiac conditions. Its effectiveness in stabilizing patients prior to surgical interventions or as a bridge to transplantation solidifies its essential role in modern medical practice. On the other hand, Extracorporeal Carbon Dioxide Removal (ECCO2R) is emerging as a novel application, gaining traction among healthcare providers looking for less invasive options to manage carbon dioxide levels in patients experiencing respiratory failure. The development of ECCO2R technologies aims to enhance patient comfort and outcomes, indicating a promising frontier in ECMO applications that could transform patient management strategies in the coming years.</p>

By End Use: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

<p>In the Extracorporeal Membrane Oxygenation (ECMO) Machine Market, hospitals hold the largest share, significantly outpacing other segments due to their high patient intake and critical care needs. This demand is driven by the increasing prevalence of cardiac and respiratory conditions that require advanced life support systems. Ambulatory surgical centers, while currently smaller, demonstrate promising potential as they adopt ECMO technology at an accelerating rate, signaling a shift towards more flexible care settings.</p>

<p>Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)</p>

<p>Hospitals represent the dominant force in the ECMO machine segment, driven by their established infrastructure and capacity to handle severe medical cases requiring prolonged support. These facilities are equipped with specialized teams and technology that can efficiently manage ECMO procedures. Conversely, ambulatory surgical centers are emerging as vital players in this landscape, characterized by their ability to offer more accessible and less resource-intensive ECMO treatments. They capitalize on the trend toward outpatient care and are increasingly integrating advanced technologies in surgical practices, making them a rapidly advancing segment in the market.</p>

By Product Type: Veno-Arterial Extracorporeal Membrane Oxygenation (Largest) vs. Veno-Venous Extracorporeal Membrane Oxygenation (Fastest-Growing)

<p>The Extracorporeal Membrane Oxygenation (ECMO) market shows significant diversity in its product type segment, dominated primarily by Veno-Arterial Extracorporeal Membrane Oxygenation (VA ECMO) which holds the largest share. VA ECMO is widely utilized in cases of cardiac failure and severe respiratory distress, making it an essential component of critical care settings. In contrast, Veno-Venous Extracorporeal Membrane Oxygenation (VV ECMO) is emerging rapidly due to its application in severe pulmonary conditions, capturing increased market interest as awareness of its benefits grows. Several factors contribute to the growth of this segment, notably the increasing incidence of respiratory failure and heart-related illnesses that necessitate advanced life support technologies. The rising adoption of ECMO in pediatric care, paired with expanding clinical guidelines advocating for ECMO use, propels both VA and VV ECMO systems. Innovations in technology and increased funding for healthcare services are further driving demand for ECMO machines across global markets, which is crucial for their role in improving patient outcomes.</p>

<p>Veno-Arterial Extracorporeal Membrane Oxygenation (Dominant) vs. Veno-Venous Extracorporeal Membrane Oxygenation (Emerging)</p>

<p>Veno-Arterial Extracorporeal Membrane Oxygenation (VA ECMO) is recognized as the dominant product type in the Extracorporeal Membrane Oxygenation Machine Market due to its extensive application in treating patients with cardiac and respiratory failures. This systems efficacy in supporting both heart and lung function establishes it as a standard in critical care. On the other hand, Veno-Venous Extracorporeal Membrane Oxygenation (VV ECMO) is identified as an emerging segment that has gained traction for managing severe respiratory disorders such as Acute Respiratory Distress Syndrome (ARDS). The VV ECMO's growing acceptance in the clinical community, along with the ongoing advancements in therapies and techniques, positions it as a vital player. As hospitals strive to enhance patient care, the adoption of these technologies is expected to continue rising, underscoring the importance of both VA and VV ECMO systems in modern medical practice.</p>

By Component: Oxygenator (Largest) vs. Pump (Fastest-Growing)

<p>In the Extracorporeal Membrane Oxygenation Machine Market, the component segment is predominantly led by the Oxygenator, which holds the largest market share. This device is crucial for providing adequate oxygenation and is widely integrated into ECMO systems, thus establishing its significant position. Following the Oxygenator, the Pump segment is gaining traction, contributing robustly to the market as it facilitates blood circulation during ECMO procedures, thus also attracting substantial interest from manufacturers and end-users alike.</p>

<p>Oxygenator (Dominant) vs. Pump (Emerging)</p>

<p>The Oxygenator stands out as the dominant component in the ECMO market, primarily due to its essential role in gas exchange, ensuring sufficient oxygenation for patients undergoing critical care. This component is designed for durability and efficiency, making it a critical focus for innovation in healthcare technology. In contrast, the Pump is emerging as a key player, enhancing its significance due to technological advancements that improve performance and reliability. As manufacturers strive to develop pumps that are more efficient and easier to use, this segment is rapidly evolving, signaling a shift towards more adaptive and user-friendly options in ECMO systems.</p>

By Technology: Centrifugal Pump Technology (Largest) vs. Roller Pump Technology (Fastest-Growing)

<p>In the Extracorporeal Membrane Oxygenation Machine Market, the distribution of market share among various technologies reveals a clear preference for Centrifugal Pump Technology, which is established as the largest segment. It dominates the market due to its efficiency and reliability in oxygenating the blood, making it the go-to choice for hospitals. Roller Pump Technology, while smaller in market share, is experiencing rapid growth as new innovations lead to improved performance and adaptability in ECMO systems.</p>

<p>Technology: Centrifugal Pump Technology (Dominant) vs. Roller Pump Technology (Emerging)</p>

<p>Centrifugal Pump Technology remains the dominant force in the Extracorporeal Membrane Oxygenation Machine Market, credited with offering smoother flows and reduced hemolysis. Its established track record makes it a staple in critical care environments, ensuring patient safety and effective blood perfusion. On the other hand, Roller Pump Technology, identified as the emerging technology, is gaining traction due to its compact design and adaptability in various clinical scenarios. Its innovative features are enhancing its appeal, making it a preferred choice for many new ECMO systems. As both technologies evolve, their distinct characteristics cater to different needs in respiratory support, influencing purchase decisions.</p>

Get more detailed insights about Extracorporeal Membrane Oxygenation Machine (ECMO) Market Research Report - Global Forecast till 2035

Regional Insights

North America : Market Leader in ECMO

North America is poised to maintain its leadership in the Extracorporeal Membrane Oxygenation (ECMO) machine market, holding a significant market share of $930.0M as of 2024. The region's growth is driven by increasing incidences of respiratory and cardiac diseases, alongside advancements in ECMO technology. Regulatory support from agencies like the FDA further catalyzes market expansion, ensuring safety and efficacy in medical devices. The competitive landscape in North America is robust, featuring key players such as Medtronic and Cleveland Medical Devices. The U.S. leads in market size, supported by a well-established healthcare infrastructure and high healthcare expenditure. The presence of innovative companies and ongoing research initiatives contribute to a dynamic market environment, positioning North America as a hub for ECMO technology development.

Europe : Emerging Market Dynamics

Europe's ECMO machine market is experiencing significant growth, with a market size of $550.0M. The increasing prevalence of chronic diseases and the rising demand for advanced medical technologies are key drivers. Regulatory frameworks, such as the EU Medical Device Regulation, ensure that products meet high safety standards, fostering consumer confidence and market growth. Leading countries in this region include Germany, France, and the UK, where healthcare systems are increasingly adopting ECMO technology. Major players like Fresenius SE and Getinge are enhancing their market presence through strategic partnerships and innovations. The competitive landscape is characterized by a focus on improving patient outcomes and expanding access to ECMO services across Europe.

Asia-Pacific : Rapidly Growing Market

The Asia-Pacific region is emerging as a significant player in the ECMO machine market, with a market size of $300.0M. Factors such as increasing healthcare expenditure, rising awareness of advanced medical technologies, and a growing patient population are driving demand. Governments are also investing in healthcare infrastructure, which supports the adoption of ECMO technology across hospitals and medical facilities. Countries like Japan and China are at the forefront of this growth, with a rising number of healthcare facilities implementing ECMO systems. Key players such as Terumo Corporation and Nipro Corporation are actively expanding their operations in this region. The competitive landscape is evolving, with a focus on innovation and improving healthcare delivery to meet the growing needs of the population.

Middle East and Africa : Emerging Healthcare Solutions

The Middle East and Africa (MEA) region is witnessing gradual growth in the ECMO machine market, currently valued at $83.66M. The increasing prevalence of cardiovascular diseases and respiratory disorders is driving demand for advanced medical technologies. Additionally, government initiatives aimed at improving healthcare infrastructure are creating a conducive environment for ECMO adoption. Countries like South Africa and the UAE are leading the way in ECMO technology implementation, supported by investments in healthcare facilities. The competitive landscape includes both local and international players, with a focus on enhancing service delivery and patient care. As healthcare systems evolve, the MEA region is expected to see a rise in ECMO usage, addressing critical health challenges.

Key Players and Competitive Insights

The Extracorporeal Membrane Oxygenation Machine Market is currently characterized by a dynamic competitive landscape, driven by technological advancements and an increasing demand for advanced respiratory support systems. Key players such as Medtronic (US), Getinge (SE), and LivaNova (GB) are strategically positioned to leverage innovation and expand their market presence. Medtronic (US) focuses on enhancing its product portfolio through continuous innovation, while Getinge (SE) emphasizes partnerships and collaborations to strengthen its market foothold. LivaNova (GB) appears to be concentrating on regional expansion, particularly in emerging markets, which collectively shapes a competitive environment that is increasingly reliant on technological differentiation and strategic alliances.

In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure is moderately fragmented, with several key players exerting influence over various segments. This fragmentation allows for a diverse range of products and services, catering to different customer needs while fostering competition among established and emerging players.

In January 2026, Medtronic (US) announced the launch of its latest ECMO system, which integrates advanced AI algorithms to improve patient monitoring and outcomes. This strategic move is significant as it positions Medtronic at the forefront of technological innovation, potentially enhancing its competitive edge in a market that increasingly values data-driven solutions. The integration of AI not only streamlines operations but also aligns with the growing trend towards digitalization in healthcare.

In December 2025, Getinge (SE) entered into a strategic partnership with a leading telehealth provider to enhance remote monitoring capabilities for ECMO patients. This collaboration is likely to expand Getinge's service offerings and improve patient care, reflecting a broader trend towards integrated healthcare solutions. By leveraging telehealth technologies, Getinge may enhance its competitive positioning in a market that is increasingly focused on patient-centric care.

In November 2025, LivaNova (GB) completed the acquisition of a regional competitor, which is expected to bolster its market share in Europe. This acquisition not only enhances LivaNova's product offerings but also provides access to new customer segments, thereby strengthening its competitive stance. The consolidation of resources and expertise through such strategic moves may lead to improved operational efficiencies and a more robust market presence.

As of February 2026, current competitive trends indicate a strong emphasis on digitalization, sustainability, and AI integration within the Extracorporeal Membrane Oxygenation Machine Market. Strategic alliances are increasingly shaping the landscape, allowing companies to pool resources and expertise to drive innovation. The competitive differentiation is likely to evolve from traditional price-based competition towards a focus on technological advancements, reliability in supply chains, and enhanced patient outcomes. This shift underscores the importance of innovation and strategic partnerships in navigating the complexities of the market.

Key Companies in the Extracorporeal Membrane Oxygenation Machine Market include

Industry Developments

Recent developments in the Global Extracorporeal Membrane Oxygenation Machine Market (ECMO) Market include significant advancements in technology and growing demand due to increased cases of respiratory and cardiac failures globally. Companies such as Getinge and Fresenius Medical Care are focusing on enhancing their product offerings through innovative designs and improved functionalities. The acquisition landscape has recently seen notable activity, particularly in April 2023, when Terumo finalized its acquisition of a smaller medical device company, strengthening its ECMO product line and expanding its market reach. 

Market valuations have seen growth, with reports indicating a surge in demand leading to heightened investments in Research and Development among companies like LivaNova and Medtronic, which are working to improve the efficiency of ECMO systems. In 2022, the COVID-19 pandemic prompted a notable reliance on ECMO machines, accelerating the production and deployment of these devices globally. Noteworthy occurrences in the past 2-3 years have led to heightened collaboration among medical institutions to develop ECMO training and protocol standards.

This period has catalyzed an extensive review of regulatory frameworks, aiming to expedite the approval process for newer ECMO technologies in various markets around the world.

Future Outlook

Extracorporeal Membrane Oxygenation Machine Market Future Outlook

The Extracorporeal Membrane Oxygenation Machine Market is projected to grow at a 5.89% CAGR from 2024 to 2035, driven by technological advancements, increasing patient populations, and rising healthcare expenditures.

New opportunities lie in:

  • Development of portable ECMO systems for <a href="https://www.marketresearchfuture.com/reports/emergency-medical-services-market-8363" target="_blank" title="emergency medical services">emergency medical services</a>.
  • Expansion into emerging markets with tailored financing solutions.
  • Integration of AI for predictive analytics in patient management.

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs.

Market Segmentation

Extracorporeal Membrane Oxygenation Machine Market End Use Outlook

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics
  • Home Care Settings

Extracorporeal Membrane Oxygenation Machine Market Component Outlook

  • Oxygenator
  • Pump
  • Cannula
  • Monitoring System
  • Control Unit

Extracorporeal Membrane Oxygenation Machine Market Technology Outlook

  • Centrifugal Pump Technology
  • Roller Pump Technology
  • Membrane Technology

Extracorporeal Membrane Oxygenation Machine Market Application Outlook

  • Cardiac Support
  • Respiratory Support
  • Extracorporeal Carbon Dioxide Removal
  • Organ Transplantation
  • Sepsis Management

Extracorporeal Membrane Oxygenation Machine Market Product Type Outlook

  • Veno-Arterial Extracorporeal Membrane Oxygenation
  • Veno-Venous Extracorporeal Membrane Oxygenation
  • Arterio-Venous Extracorporeal Membrane Oxygenation

Report Scope

MARKET SIZE 2024 1863.66(USD Million)
MARKET SIZE 2025 1973.43(USD Million)
MARKET SIZE 2035 3497.62(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 5.89% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Medtronic (US), Getinge (SE), LivaNova (GB), Fresenius SE (DE), Terumo Corporation (JP), Maquet (DE), Nipro Corporation (JP), Cleveland Medical Devices (US)
Segments Covered Application, End Use, Product Type, Component, Technology
Key Market Opportunities Advancements in technology and increasing demand for critical care solutions drive growth in the Extracorporeal Membrane Oxygenation Machine Market.
Key Market Dynamics Technological advancements and regulatory changes drive innovation and competition in the Extracorporeal Membrane Oxygenation Machine market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation for the Extracorporeal Membrane Oxygenation Machine Market by 2035?

<p>The projected market valuation for the Extracorporeal Membrane Oxygenation Machine Market is expected to reach 3497.62 USD Million by 2035.</p>

Which companies are considered key players in the Extracorporeal Membrane Oxygenation Machine Market?

<p>Key players in the market include Medtronic, Getinge, LivaNova, Fresenius SE, Terumo Corporation, Maquet, Nipro Corporation, and Cleveland Medical Devices.</p>

What was the overall market valuation for the Extracorporeal Membrane Oxygenation Machine Market in 2024?

<p>The overall market valuation for the Extracorporeal Membrane Oxygenation Machine Market was 1863.66 USD Million in 2024.</p>

What is the expected CAGR for the Extracorporeal Membrane Oxygenation Machine Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Extracorporeal Membrane Oxygenation Machine Market during the forecast period 2025 - 2035 is 5.89%.</p>

How does the market segment for Cardiac Support perform in terms of valuation?

<p>The market segment for Cardiac Support is valued between 500.0 and 950.0 USD Million.</p>

What are the projected valuations for Veno-Venous Extracorporeal Membrane Oxygenation by 2035?

<p>The projected valuation for Veno-Venous Extracorporeal Membrane Oxygenation is expected to range from 800.0 to 1300.0 USD Million.</p>

Which end-use segment is expected to have the highest valuation in the Extracorporeal Membrane Oxygenation Machine Market?

<p>The Hospitals segment is expected to have the highest valuation, projected between 800.0 and 1500.0 USD Million.</p>

What is the valuation range for the Oxygenator component in the market?

<p>The valuation range for the Oxygenator component is between 500.0 and 950.0 USD Million.</p>

How does the market for Membrane Technology compare to other technologies in terms of valuation?

<p>The market for Membrane Technology is valued between 763.66 and 1497.62 USD Million, indicating a strong position compared to other technologies.</p>

What is the expected performance of the Extracorporeal Membrane Oxygenation Machine Market by 2035?

<p>The Extracorporeal Membrane Oxygenation Machine Market is expected to demonstrate robust growth, reaching a valuation of 3497.62 USD Million by 2035.</p>

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. | 1.1 EXECUTIVE SUMMARY
    2. | | 1.1.1 Market Overview
    3. | | 1.1.2 Key Findings
    4. | | 1.1.3 Market Segmentation
    5. | | 1.1.4 Competitive Landscape
    6. | | 1.1.5 Challenges and Opportunities
    7. | | 1.1.6 Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. | 2.1 MARKET INTRODUCTION
    2. | | 2.1.1 Definition
    3. | | 2.1.2 Scope of the study
    4. | | | 2.1.2.1 Research Objective
    5. | | | 2.1.2.2 Assumption
    6. | | | 2.1.2.3 Limitations
    7. | 2.2 RESEARCH METHODOLOGY
    8. | | 2.2.1 Overview
    9. | | 2.2.2 Data Mining
    10. | | 2.2.3 Secondary Research
    11. | | 2.2.4 Primary Research
    12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
    13. | | | 2.2.4.2 Breakdown of Primary Respondents
    14. | | 2.2.5 Forecasting Model
    15. | | 2.2.6 Market Size Estimation
    16. | | | 2.2.6.1 Bottom-Up Approach
    17. | | | 2.2.6.2 Top-Down Approach
    18. | | 2.2.7 Data Triangulation
    19. | | 2.2.8 Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. | 3.1 MARKET DYNAMICS
    2. | | 3.1.1 Overview
    3. | | 3.1.2 Drivers
    4. | | 3.1.3 Restraints
    5. | | 3.1.4 Opportunities
    6. | 3.2 MARKET FACTOR ANALYSIS
    7. | | 3.2.1 Value chain Analysis
    8. | | 3.2.2 Porter's Five Forces Analysis
    9. | | | 3.2.2.1 Bargaining Power of Suppliers
    10. | | | 3.2.2.2 Bargaining Power of Buyers
    11. | | | 3.2.2.3 Threat of New Entrants
    12. | | | 3.2.2.4 Threat of Substitutes
    13. | | | 3.2.2.5 Intensity of Rivalry
    14. | | 3.2.3 COVID-19 Impact Analysis
    15. | | | 3.2.3.1 Market Impact Analysis
    16. | | | 3.2.3.2 Regional Impact
    17. | | | 3.2.3.3 Opportunity and Threat Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. | 4.1 Healthcare, BY Application (USD Million)
    2. | | 4.1.1 Cardiac Support
    3. | | 4.1.2 Respiratory Support
    4. | | 4.1.3 Extracorporeal Carbon Dioxide Removal
    5. | | 4.1.4 Organ Transplantation
    6. | | 4.1.5 Sepsis Management
    7. | 4.2 Healthcare, BY End Use (USD Million)
    8. | | 4.2.1 Hospitals
    9. | | 4.2.2 Ambulatory Surgical Centers
    10. | | 4.2.3 Specialized Clinics
    11. | | 4.2.4 Home Care Settings
    12. | 4.3 Healthcare, BY Product Type (USD Million)
    13. | | 4.3.1 Veno-Arterial Extracorporeal Membrane Oxygenation
    14. | | 4.3.2 Veno-Venous Extracorporeal Membrane Oxygenation
    15. | | 4.3.3 Arterio-Venous Extracorporeal Membrane Oxygenation
    16. | 4.4 Healthcare, BY Component (USD Million)
    17. | | 4.4.1 Oxygenator
    18. | | 4.4.2 Pump
    19. | | 4.4.3 Cannula
    20. | | 4.4.4 Monitoring System
    21. | | 4.4.5 Control Unit
    22. | 4.5 Healthcare, BY Technology (USD Million)
    23. | | 4.5.1 Centrifugal Pump Technology
    24. | | 4.5.2 Roller Pump Technology
    25. | | 4.5.3 Membrane Technology
    26. | 4.6 Healthcare, BY Region (USD Million)
    27. | | 4.6.1 North America
    28. | | | 4.6.1.1 US
    29. | | | 4.6.1.2 Canada
    30. | | 4.6.2 Europe
    31. | | | 4.6.2.1 Germany
    32. | | | 4.6.2.2 UK
    33. | | | 4.6.2.3 France
    34. | | | 4.6.2.4 Russia
    35. | | | 4.6.2.5 Italy
    36. | | | 4.6.2.6 Spain
    37. | | | 4.6.2.7 Rest of Europe
    38. | | 4.6.3 APAC
    39. | | | 4.6.3.1 China
    40. | | | 4.6.3.2 India
    41. | | | 4.6.3.3 Japan
    42. | | | 4.6.3.4 South Korea
    43. | | | 4.6.3.5 Malaysia
    44. | | | 4.6.3.6 Thailand
    45. | | | 4.6.3.7 Indonesia
    46. | | | 4.6.3.8 Rest of APAC
    47. | | 4.6.4 South America
    48. | | | 4.6.4.1 Brazil
    49. | | | 4.6.4.2 Mexico
    50. | | | 4.6.4.3 Argentina
    51. | | | 4.6.4.4 Rest of South America
    52. | | 4.6.5 MEA
    53. | | | 4.6.5.1 GCC Countries
    54. | | | 4.6.5.2 South Africa
    55. | | | 4.6.5.3 Rest of MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. | 5.1 Competitive Landscape
    2. | | 5.1.1 Overview
    3. | | 5.1.2 Competitive Analysis
    4. | | 5.1.3 Market share Analysis
    5. | | 5.1.4 Major Growth Strategy in the Healthcare
    6. | | 5.1.5 Competitive Benchmarking
    7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
    8. | | 5.1.7 Key developments and growth strategies
    9. | | | 5.1.7.1 New Product Launch/Service Deployment
    10. | | | 5.1.7.2 Merger & Acquisitions
    11. | | | 5.1.7.3 Joint Ventures
    12. | | 5.1.8 Major Players Financial Matrix
    13. | | | 5.1.8.1 Sales and Operating Income
    14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
    15. | 5.2 Company Profiles
    16. | | 5.2.1 Medtronic (US)
    17. | | | 5.2.1.1 Financial Overview
    18. | | | 5.2.1.2 Products Offered
    19. | | | 5.2.1.3 Key Developments
    20. | | | 5.2.1.4 SWOT Analysis
    21. | | | 5.2.1.5 Key Strategies
    22. | | 5.2.2 Getinge (SE)
    23. | | | 5.2.2.1 Financial Overview
    24. | | | 5.2.2.2 Products Offered
    25. | | | 5.2.2.3 Key Developments
    26. | | | 5.2.2.4 SWOT Analysis
    27. | | | 5.2.2.5 Key Strategies
    28. | | 5.2.3 LivaNova (GB)
    29. | | | 5.2.3.1 Financial Overview
    30. | | | 5.2.3.2 Products Offered
    31. | | | 5.2.3.3 Key Developments
    32. | | | 5.2.3.4 SWOT Analysis
    33. | | | 5.2.3.5 Key Strategies
    34. | | 5.2.4 Fresenius SE (DE)
    35. | | | 5.2.4.1 Financial Overview
    36. | | | 5.2.4.2 Products Offered
    37. | | | 5.2.4.3 Key Developments
    38. | | | 5.2.4.4 SWOT Analysis
    39. | | | 5.2.4.5 Key Strategies
    40. | | 5.2.5 Terumo Corporation (JP)
    41. | | | 5.2.5.1 Financial Overview
    42. | | | 5.2.5.2 Products Offered
    43. | | | 5.2.5.3 Key Developments
    44. | | | 5.2.5.4 SWOT Analysis
    45. | | | 5.2.5.5 Key Strategies
    46. | | 5.2.6 Maquet (DE)
    47. | | | 5.2.6.1 Financial Overview
    48. | | | 5.2.6.2 Products Offered
    49. | | | 5.2.6.3 Key Developments
    50. | | | 5.2.6.4 SWOT Analysis
    51. | | | 5.2.6.5 Key Strategies
    52. | | 5.2.7 Nipro Corporation (JP)
    53. | | | 5.2.7.1 Financial Overview
    54. | | | 5.2.7.2 Products Offered
    55. | | | 5.2.7.3 Key Developments
    56. | | | 5.2.7.4 SWOT Analysis
    57. | | | 5.2.7.5 Key Strategies
    58. | | 5.2.8 Cleveland Medical Devices (US)
    59. | | | 5.2.8.1 Financial Overview
    60. | | | 5.2.8.2 Products Offered
    61. | | | 5.2.8.3 Key Developments
    62. | | | 5.2.8.4 SWOT Analysis
    63. | | | 5.2.8.5 Key Strategies
    64. | 5.3 Appendix
    65. | | 5.3.1 References
    66. | | 5.3.2 Related Reports
  6. LIST OF FIGURES
    1. | 6.1 MARKET SYNOPSIS
    2. | 6.2 NORTH AMERICA MARKET ANALYSIS
    3. | 6.3 US MARKET ANALYSIS BY APPLICATION
    4. | 6.4 US MARKET ANALYSIS BY END USE
    5. | 6.5 US MARKET ANALYSIS BY PRODUCT TYPE
    6. | 6.6 US MARKET ANALYSIS BY COMPONENT
    7. | 6.7 US MARKET ANALYSIS BY TECHNOLOGY
    8. | 6.8 CANADA MARKET ANALYSIS BY APPLICATION
    9. | 6.9 CANADA MARKET ANALYSIS BY END USE
    10. | 6.10 CANADA MARKET ANALYSIS BY PRODUCT TYPE
    11. | 6.11 CANADA MARKET ANALYSIS BY COMPONENT
    12. | 6.12 CANADA MARKET ANALYSIS BY TECHNOLOGY
    13. | 6.13 EUROPE MARKET ANALYSIS
    14. | 6.14 GERMANY MARKET ANALYSIS BY APPLICATION
    15. | 6.15 GERMANY MARKET ANALYSIS BY END USE
    16. | 6.16 GERMANY MARKET ANALYSIS BY PRODUCT TYPE
    17. | 6.17 GERMANY MARKET ANALYSIS BY COMPONENT
    18. | 6.18 GERMANY MARKET ANALYSIS BY TECHNOLOGY
    19. | 6.19 UK MARKET ANALYSIS BY APPLICATION
    20. | 6.20 UK MARKET ANALYSIS BY END USE
    21. | 6.21 UK MARKET ANALYSIS BY PRODUCT TYPE
    22. | 6.22 UK MARKET ANALYSIS BY COMPONENT
    23. | 6.23 UK MARKET ANALYSIS BY TECHNOLOGY
    24. | 6.24 FRANCE MARKET ANALYSIS BY APPLICATION
    25. | 6.25 FRANCE MARKET ANALYSIS BY END USE
    26. | 6.26 FRANCE MARKET ANALYSIS BY PRODUCT TYPE
    27. | 6.27 FRANCE MARKET ANALYSIS BY COMPONENT
    28. | 6.28 FRANCE MARKET ANALYSIS BY TECHNOLOGY
    29. | 6.29 RUSSIA MARKET ANALYSIS BY APPLICATION
    30. | 6.30 RUSSIA MARKET ANALYSIS BY END USE
    31. | 6.31 RUSSIA MARKET ANALYSIS BY PRODUCT TYPE
    32. | 6.32 RUSSIA MARKET ANALYSIS BY COMPONENT
    33. | 6.33 RUSSIA MARKET ANALYSIS BY TECHNOLOGY
    34. | 6.34 ITALY MARKET ANALYSIS BY APPLICATION
    35. | 6.35 ITALY MARKET ANALYSIS BY END USE
    36. | 6.36 ITALY MARKET ANALYSIS BY PRODUCT TYPE
    37. | 6.37 ITALY MARKET ANALYSIS BY COMPONENT
    38. | 6.38 ITALY MARKET ANALYSIS BY TECHNOLOGY
    39. | 6.39 SPAIN MARKET ANALYSIS BY APPLICATION
    40. | 6.40 SPAIN MARKET ANALYSIS BY END USE
    41. | 6.41 SPAIN MARKET ANALYSIS BY PRODUCT TYPE
    42. | 6.42 SPAIN MARKET ANALYSIS BY COMPONENT
    43. | 6.43 SPAIN MARKET ANALYSIS BY TECHNOLOGY
    44. | 6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    45. | 6.45 REST OF EUROPE MARKET ANALYSIS BY END USE
    46. | 6.46 REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE
    47. | 6.47 REST OF EUROPE MARKET ANALYSIS BY COMPONENT
    48. | 6.48 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY
    49. | 6.49 APAC MARKET ANALYSIS
    50. | 6.50 CHINA MARKET ANALYSIS BY APPLICATION
    51. | 6.51 CHINA MARKET ANALYSIS BY END USE
    52. | 6.52 CHINA MARKET ANALYSIS BY PRODUCT TYPE
    53. | 6.53 CHINA MARKET ANALYSIS BY COMPONENT
    54. | 6.54 CHINA MARKET ANALYSIS BY TECHNOLOGY
    55. | 6.55 INDIA MARKET ANALYSIS BY APPLICATION
    56. | 6.56 INDIA MARKET ANALYSIS BY END USE
    57. | 6.57 INDIA MARKET ANALYSIS BY PRODUCT TYPE
    58. | 6.58 INDIA MARKET ANALYSIS BY COMPONENT
    59. | 6.59 INDIA MARKET ANALYSIS BY TECHNOLOGY
    60. | 6.60 JAPAN MARKET ANALYSIS BY APPLICATION
    61. | 6.61 JAPAN MARKET ANALYSIS BY END USE
    62. | 6.62 JAPAN MARKET ANALYSIS BY PRODUCT TYPE
    63. | 6.63 JAPAN MARKET ANALYSIS BY COMPONENT
    64. | 6.64 JAPAN MARKET ANALYSIS BY TECHNOLOGY
    65. | 6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    66. | 6.66 SOUTH KOREA MARKET ANALYSIS BY END USE
    67. | 6.67 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE
    68. | 6.68 SOUTH KOREA MARKET ANALYSIS BY COMPONENT
    69. | 6.69 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
    70. | 6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION
    71. | 6.71 MALAYSIA MARKET ANALYSIS BY END USE
    72. | 6.72 MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE
    73. | 6.73 MALAYSIA MARKET ANALYSIS BY COMPONENT
    74. | 6.74 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY
    75. | 6.75 THAILAND MARKET ANALYSIS BY APPLICATION
    76. | 6.76 THAILAND MARKET ANALYSIS BY END USE
    77. | 6.77 THAILAND MARKET ANALYSIS BY PRODUCT TYPE
    78. | 6.78 THAILAND MARKET ANALYSIS BY COMPONENT
    79. | 6.79 THAILAND MARKET ANALYSIS BY TECHNOLOGY
    80. | 6.80 INDONESIA MARKET ANALYSIS BY APPLICATION
    81. | 6.81 INDONESIA MARKET ANALYSIS BY END USE
    82. | 6.82 INDONESIA MARKET ANALYSIS BY PRODUCT TYPE
    83. | 6.83 INDONESIA MARKET ANALYSIS BY COMPONENT
    84. | 6.84 INDONESIA MARKET ANALYSIS BY TECHNOLOGY
    85. | 6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION
    86. | 6.86 REST OF APAC MARKET ANALYSIS BY END USE
    87. | 6.87 REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE
    88. | 6.88 REST OF APAC MARKET ANALYSIS BY COMPONENT
    89. | 6.89 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY
    90. | 6.90 SOUTH AMERICA MARKET ANALYSIS
    91. | 6.91 BRAZIL MARKET ANALYSIS BY APPLICATION
    92. | 6.92 BRAZIL MARKET ANALYSIS BY END USE
    93. | 6.93 BRAZIL MARKET ANALYSIS BY PRODUCT TYPE
    94. | 6.94 BRAZIL MARKET ANALYSIS BY COMPONENT
    95. | 6.95 BRAZIL MARKET ANALYSIS BY TECHNOLOGY
    96. | 6.96 MEXICO MARKET ANALYSIS BY APPLICATION
    97. | 6.97 MEXICO MARKET ANALYSIS BY END USE
    98. | 6.98 MEXICO MARKET ANALYSIS BY PRODUCT TYPE
    99. | 6.99 MEXICO MARKET ANALYSIS BY COMPONENT
    100. | 6.100 MEXICO MARKET ANALYSIS BY TECHNOLOGY
    101. | 6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION
    102. | 6.102 ARGENTINA MARKET ANALYSIS BY END USE
    103. | 6.103 ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE
    104. | 6.104 ARGENTINA MARKET ANALYSIS BY COMPONENT
    105. | 6.105 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY
    106. | 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    107. | 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
    108. | 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
    109. | 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY COMPONENT
    110. | 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
    111. | 6.111 MEA MARKET ANALYSIS
    112. | 6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    113. | 6.113 GCC COUNTRIES MARKET ANALYSIS BY END USE
    114. | 6.114 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE
    115. | 6.115 GCC COUNTRIES MARKET ANALYSIS BY COMPONENT
    116. | 6.116 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY
    117. | 6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    118. | 6.118 SOUTH AFRICA MARKET ANALYSIS BY END USE
    119. | 6.119 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE
    120. | 6.120 SOUTH AFRICA MARKET ANALYSIS BY COMPONENT
    121. | 6.121 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY
    122. | 6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION
    123. | 6.123 REST OF MEA MARKET ANALYSIS BY END USE
    124. | 6.124 REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE
    125. | 6.125 REST OF MEA MARKET ANALYSIS BY COMPONENT
    126. | 6.126 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY
    127. | 6.127 KEY BUYING CRITERIA OF HEALTHCARE
    128. | 6.128 RESEARCH PROCESS OF MRFR
    129. | 6.129 DRO ANALYSIS OF HEALTHCARE
    130. | 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    131. | 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    132. | 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
    133. | 6.133 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    134. | 6.134 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
    135. | 6.135 HEALTHCARE, BY END USE, 2024 (% SHARE)
    136. | 6.136 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million)
    137. | 6.137 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
    138. | 6.138 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    139. | 6.139 HEALTHCARE, BY COMPONENT, 2024 (% SHARE)
    140. | 6.140 HEALTHCARE, BY COMPONENT, 2024 TO 2035 (USD Million)
    141. | 6.141 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
    142. | 6.142 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
    143. | 6.143 BENCHMARKING OF MAJOR COMPETITORS
  7. LIST OF TABLES
    1. | 7.1 LIST OF ASSUMPTIONS
    2. | | 7.1.1
    3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
    4. | | 7.2.1 BY APPLICATION, 2026-2035 (USD Million)
    5. | | 7.2.2 BY END USE, 2026-2035 (USD Million)
    6. | | 7.2.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    7. | | 7.2.4 BY COMPONENT, 2026-2035 (USD Million)
    8. | | 7.2.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    9. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
    10. | | 7.3.1 BY APPLICATION, 2026-2035 (USD Million)
    11. | | 7.3.2 BY END USE, 2026-2035 (USD Million)
    12. | | 7.3.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    13. | | 7.3.4 BY COMPONENT, 2026-2035 (USD Million)
    14. | | 7.3.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    15. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
    16. | | 7.4.1 BY APPLICATION, 2026-2035 (USD Million)
    17. | | 7.4.2 BY END USE, 2026-2035 (USD Million)
    18. | | 7.4.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    19. | | 7.4.4 BY COMPONENT, 2026-2035 (USD Million)
    20. | | 7.4.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    21. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
    22. | | 7.5.1 BY APPLICATION, 2026-2035 (USD Million)
    23. | | 7.5.2 BY END USE, 2026-2035 (USD Million)
    24. | | 7.5.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    25. | | 7.5.4 BY COMPONENT, 2026-2035 (USD Million)
    26. | | 7.5.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    27. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
    28. | | 7.6.1 BY APPLICATION, 2026-2035 (USD Million)
    29. | | 7.6.2 BY END USE, 2026-2035 (USD Million)
    30. | | 7.6.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    31. | | 7.6.4 BY COMPONENT, 2026-2035 (USD Million)
    32. | | 7.6.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    33. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
    34. | | 7.7.1 BY APPLICATION, 2026-2035 (USD Million)
    35. | | 7.7.2 BY END USE, 2026-2035 (USD Million)
    36. | | 7.7.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    37. | | 7.7.4 BY COMPONENT, 2026-2035 (USD Million)
    38. | | 7.7.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    39. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
    40. | | 7.8.1 BY APPLICATION, 2026-2035 (USD Million)
    41. | | 7.8.2 BY END USE, 2026-2035 (USD Million)
    42. | | 7.8.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    43. | | 7.8.4 BY COMPONENT, 2026-2035 (USD Million)
    44. | | 7.8.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    45. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
    46. | | 7.9.1 BY APPLICATION, 2026-2035 (USD Million)
    47. | | 7.9.2 BY END USE, 2026-2035 (USD Million)
    48. | | 7.9.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    49. | | 7.9.4 BY COMPONENT, 2026-2035 (USD Million)
    50. | | 7.9.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    51. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
    52. | | 7.10.1 BY APPLICATION, 2026-2035 (USD Million)
    53. | | 7.10.2 BY END USE, 2026-2035 (USD Million)
    54. | | 7.10.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    55. | | 7.10.4 BY COMPONENT, 2026-2035 (USD Million)
    56. | | 7.10.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    57. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
    58. | | 7.11.1 BY APPLICATION, 2026-2035 (USD Million)
    59. | | 7.11.2 BY END USE, 2026-2035 (USD Million)
    60. | | 7.11.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    61. | | 7.11.4 BY COMPONENT, 2026-2035 (USD Million)
    62. | | 7.11.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    63. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
    64. | | 7.12.1 BY APPLICATION, 2026-2035 (USD Million)
    65. | | 7.12.2 BY END USE, 2026-2035 (USD Million)
    66. | | 7.12.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    67. | | 7.12.4 BY COMPONENT, 2026-2035 (USD Million)
    68. | | 7.12.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    69. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
    70. | | 7.13.1 BY APPLICATION, 2026-2035 (USD Million)
    71. | | 7.13.2 BY END USE, 2026-2035 (USD Million)
    72. | | 7.13.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    73. | | 7.13.4 BY COMPONENT, 2026-2035 (USD Million)
    74. | | 7.13.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    75. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
    76. | | 7.14.1 BY APPLICATION, 2026-2035 (USD Million)
    77. | | 7.14.2 BY END USE, 2026-2035 (USD Million)
    78. | | 7.14.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    79. | | 7.14.4 BY COMPONENT, 2026-2035 (USD Million)
    80. | | 7.14.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    81. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
    82. | | 7.15.1 BY APPLICATION, 2026-2035 (USD Million)
    83. | | 7.15.2 BY END USE, 2026-2035 (USD Million)
    84. | | 7.15.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    85. | | 7.15.4 BY COMPONENT, 2026-2035 (USD Million)
    86. | | 7.15.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    87. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
    88. | | 7.16.1 BY APPLICATION, 2026-2035 (USD Million)
    89. | | 7.16.2 BY END USE, 2026-2035 (USD Million)
    90. | | 7.16.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    91. | | 7.16.4 BY COMPONENT, 2026-2035 (USD Million)
    92. | | 7.16.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    93. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
    94. | | 7.17.1 BY APPLICATION, 2026-2035 (USD Million)
    95. | | 7.17.2 BY END USE, 2026-2035 (USD Million)
    96. | | 7.17.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    97. | | 7.17.4 BY COMPONENT, 2026-2035 (USD Million)
    98. | | 7.17.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    99. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
    100. | | 7.18.1 BY APPLICATION, 2026-2035 (USD Million)
    101. | | 7.18.2 BY END USE, 2026-2035 (USD Million)
    102. | | 7.18.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    103. | | 7.18.4 BY COMPONENT, 2026-2035 (USD Million)
    104. | | 7.18.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    105. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
    106. | | 7.19.1 BY APPLICATION, 2026-2035 (USD Million)
    107. | | 7.19.2 BY END USE, 2026-2035 (USD Million)
    108. | | 7.19.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    109. | | 7.19.4 BY COMPONENT, 2026-2035 (USD Million)
    110. | | 7.19.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    111. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
    112. | | 7.20.1 BY APPLICATION, 2026-2035 (USD Million)
    113. | | 7.20.2 BY END USE, 2026-2035 (USD Million)
    114. | | 7.20.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    115. | | 7.20.4 BY COMPONENT, 2026-2035 (USD Million)
    116. | | 7.20.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    117. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
    118. | | 7.21.1 BY APPLICATION, 2026-2035 (USD Million)
    119. | | 7.21.2 BY END USE, 2026-2035 (USD Million)
    120. | | 7.21.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    121. | | 7.21.4 BY COMPONENT, 2026-2035 (USD Million)
    122. | | 7.21.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    123. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
    124. | | 7.22.1 BY APPLICATION, 2026-2035 (USD Million)
    125. | | 7.22.2 BY END USE, 2026-2035 (USD Million)
    126. | | 7.22.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    127. | | 7.22.4 BY COMPONENT, 2026-2035 (USD Million)
    128. | | 7.22.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    129. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
    130. | | 7.23.1 BY APPLICATION, 2026-2035 (USD Million)
    131. | | 7.23.2 BY END USE, 2026-2035 (USD Million)
    132. | | 7.23.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    133. | | 7.23.4 BY COMPONENT, 2026-2035 (USD Million)
    134. | | 7.23.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    135. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
    136. | | 7.24.1 BY APPLICATION, 2026-2035 (USD Million)
    137. | | 7.24.2 BY END USE, 2026-2035 (USD Million)
    138. | | 7.24.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    139. | | 7.24.4 BY COMPONENT, 2026-2035 (USD Million)
    140. | | 7.24.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    141. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
    142. | | 7.25.1 BY APPLICATION, 2026-2035 (USD Million)
    143. | | 7.25.2 BY END USE, 2026-2035 (USD Million)
    144. | | 7.25.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    145. | | 7.25.4 BY COMPONENT, 2026-2035 (USD Million)
    146. | | 7.25.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    147. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
    148. | | 7.26.1 BY APPLICATION, 2026-2035 (USD Million)
    149. | | 7.26.2 BY END USE, 2026-2035 (USD Million)
    150. | | 7.26.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    151. | | 7.26.4 BY COMPONENT, 2026-2035 (USD Million)
    152. | | 7.26.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    153. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
    154. | | 7.27.1 BY APPLICATION, 2026-2035 (USD Million)
    155. | | 7.27.2 BY END USE, 2026-2035 (USD Million)
    156. | | 7.27.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    157. | | 7.27.4 BY COMPONENT, 2026-2035 (USD Million)
    158. | | 7.27.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    159. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
    160. | | 7.28.1 BY APPLICATION, 2026-2035 (USD Million)
    161. | | 7.28.2 BY END USE, 2026-2035 (USD Million)
    162. | | 7.28.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    163. | | 7.28.4 BY COMPONENT, 2026-2035 (USD Million)
    164. | | 7.28.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    165. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
    166. | | 7.29.1 BY APPLICATION, 2026-2035 (USD Million)
    167. | | 7.29.2 BY END USE, 2026-2035 (USD Million)
    168. | | 7.29.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    169. | | 7.29.4 BY COMPONENT, 2026-2035 (USD Million)
    170. | | 7.29.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    171. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
    172. | | 7.30.1 BY APPLICATION, 2026-2035 (USD Million)
    173. | | 7.30.2 BY END USE, 2026-2035 (USD Million)
    174. | | 7.30.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
    175. | | 7.30.4 BY COMPONENT, 2026-2035 (USD Million)
    176. | | 7.30.5 BY TECHNOLOGY, 2026-2035 (USD Million)
    177. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    178. | | 7.31.1
    179. | 7.32 ACQUISITION/PARTNERSHIP
    180. | | 7.32.1

Healthcare Market Segmentation

Healthcare By Application (USD Million, 2022-2035)

  • Cardiac Support
  • Respiratory Support
  • Extracorporeal Carbon Dioxide Removal
  • Organ Transplantation
  • Sepsis Management

Healthcare By End Use (USD Million, 2022-2035)

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics
  • Home Care Settings

Healthcare By Product Type (USD Million, 2022-2035)

  • Veno-Arterial Extracorporeal Membrane Oxygenation
  • Veno-Venous Extracorporeal Membrane Oxygenation
  • Arterio-Venous Extracorporeal Membrane Oxygenation

Healthcare By Component (USD Million, 2022-2035)

  • Oxygenator
  • Pump
  • Cannula
  • Monitoring System
  • Control Unit

Healthcare By Technology (USD Million, 2022-2035)

  • Centrifugal Pump Technology
  • Roller Pump Technology
  • Membrane Technology
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓